We are live on
!
Find out more
iBio
IBIO
IBIO
37 hedge funds and large institutions have $990K invested in iBio in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,570% more call options, than puts
Call options by funds: $167K | Put options by funds: $10K
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
1.07% more ownership
Funds ownership: 0.03% → 1.09% (+1.1%)
14% less funds holding
Funds holding: 43 → 37 (-6)
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
80% less capital invested
Capital invested by funds: $4.97M → $990K (-$3.98M)
Holders
37
Holders Change
-6
Holders Change %
-13.95%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
5
Closed
20
Calls
$167K
Puts
$10K
Net Calls
+$157K
Net Calls Change
+$145K
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$830K |
| 2 |
Renaissance Technologies
New York
|
+$558K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$190K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$125K |
| 5 |
Two Sigma Investments
New York
|
+$90.4K |
Top Sellers
| 1 |
E
Ergoteles
New York
|
-$142K |
| 2 |
Millennium Management
New York
|
-$44.8K |
| 3 |
N
Natixis
Paris,
France
|
-$33K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$31K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$27K |
